|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-8-30
|
|
pubmed:abstractText |
To date, there are no data on long-term use of enteric-coated mycophenolate sodium (EC-MPS; myfortic) from time of renal transplantation. We report the first long-term safety and efficacy data on EC-MPS when administered for up to 3 years post transplant.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0301-0430
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
112-9
|
|
pubmed:meshHeading |
pubmed-meshheading:16939067-Adolescent,
pubmed-meshheading:16939067-Adult,
pubmed-meshheading:16939067-Aged,
pubmed-meshheading:16939067-Double-Blind Method,
pubmed-meshheading:16939067-Female,
pubmed-meshheading:16939067-Humans,
pubmed-meshheading:16939067-Immunosuppressive Agents,
pubmed-meshheading:16939067-Kidney Transplantation,
pubmed-meshheading:16939067-Male,
pubmed-meshheading:16939067-Middle Aged,
pubmed-meshheading:16939067-Mycophenolic Acid,
pubmed-meshheading:16939067-Prospective Studies,
pubmed-meshheading:16939067-Safety,
pubmed-meshheading:16939067-Tablets, Enteric-Coated,
pubmed-meshheading:16939067-Time Factors
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients.
|
|
pubmed:affiliation |
Renal Unit, Careggi University Hospital, Florence, Italy. salvadorim@ao-careggi.toscana.it
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
